Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions

To Determine Bioequivalence Under Fed Conditions Clinical Trial

Official title:
Randomized, 3-Way Crossover, Comparative Bioequivalence Study of Par Pharmaceutical Inc. (USA) and Oclassen Pharmaceuticals Inc. (USA)(Monodox(R)) Doxycycline Monohydrate Equivalent to 100 mg Doxycycline Administered as a Single Dose of 100 mg In Healthy Adult Males Under Fasting and Fed Conditions

Status Completed

Clinical Trial Summary

The purpose of this study is to compare the single-dose bioequivalence of Par and Oclassen doxycycline monohydrate 100 mg.

Clinical Trial Description

To compare the single-dose bioequivalence of Par and Oclassen (Monodox(R)), 100 mg doxycycline under fed and fasting conditions. ;

Study Design

Related Conditions & MeSH terms

Disease
Malnutrition
To Determine Bioequivalence Under Fed Conditions

Clinical Trial Details

NCT number	NCT01380496
Study type	Interventional
Source	Par Pharmaceutical, Inc.
Contact
Status	Completed
Phase	Phase 1
Start date	November 1999
Completion date	November 1999

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00652600` - Bioavailability Study of Propranolol Under Fed Conditions	Phase 1
Completed	`NCT00652821` - Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions	Phase 1
Completed	`NCT00652873` - Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions	Phase 1
Completed	`NCT00652704` - Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions	Phase 1
Completed	`NCT00652730` - Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions	Phase 1
Completed	`NCT05337969` - The Study Aims to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Assessed.	N/A
Completed	`NCT05329857` - The Study Intends to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Evaluated.	N/A
Completed	`NCT00653003` - Bioavailability Study of Leflunomide Tablets Under Fed Conditions	Phase 1
Completed	`NCT01380431` - A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study	Phase 1